NeuroMetrix/Cyberkinetics Joint Venture Focuses On Peripheral Nerve Repair
This article was originally published in The Gray Sheet
Executive Summary
NeuroMetrix will help Cyberkinetics develop and commercialize a device to treat peripheral nerve injury based on the latter company's Andara OFS spinal nerve repair neurostimulation platform under a joint venture agreement announced Nov. 14
You may also be interested in...
Cyberkinetics Andara OFS Spinal Nerve Repair System To Launch By Year-End
Cyberkinetics Neurotechnology Systems is gearing up to launch its Andara OFS spinal nerve repair system "as early as the fourth quarter" of this year, the firm says, pending approval of a humanitarian device exemption application announced Feb. 20
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.